Local 12: New robotic technology helps diagnose lung cancer sooner
UC experts demonstrate new bronchoscopy methods
Lung cancer is the deadliest cancer in the U.S., and Ohio, Kentucky and Indiana report higher rates of lung cancer compared to the overall national rate.
Now, University of Cincinnati researchers are using new robotic technology that makes detecting and diagnosing lung cancer easier.
Christopher Radchenko, MD, and Alejandro Aragaki-Nakahodo, MD, both assistant professors in the Department of Internal Medicine in UC's College of Medicine and UC Health physicians, lead the use of the new Monarch Platform technology.
The new technology is a camera attached to a flexible thin tube which doctors can navigate to the lungs with a remote controller. The researchers said the technology should detect lung cancers sooner and be more accurate than previous systems.
Featured photo at top of lungs courtesy of iStock.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.